Bladder Tumor Contains Higher N7-Methylguanine Levels in DNA than Adjacent Normal Bladder Epithelium
Authors:
Open Access
- 1 April 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (4) , 740-743
Abstract
Schistosoma haematobium–infected patients are more likely to develop bladder cancer and be more exposed to carcinogenic N-nitroso compounds than uninfected patients. As N7-methylguanine is a marker of exposure to methylating agents of this type, we have measured N7-methyldeoxyguanosine 3′-monophosphate (N7-MedGp) by 32P postlabeling. DNA was isolated from 42 paired normal and tumor tissue of Egyptians with bladder cancer. N7-MedGp was detected in DNA from 93% of the tumors and 74% of the normal bladder tissue samples. Adduct levels were highly variable and ranged from 0.04 to 6.4 and from 0.02 to 0.72 μmol/mol deoxyguanosine 3′-monophosphate (dGp) in tumor and normal DNA, respectively. N7-MedGp levels in normal and tumor DNA were highly correlated with one another (P = 0.007). The mean difference (95% confidence interval) in adduct levels between tumor and normal DNA was 0.21 (0.13-0.32) μmol/mol dGp and this was statistically significant (P < 0.001). The adduct ratio (tumor DNA/normal DNA) varied between 0.2 and 136 (median, 4.6). N7-MedGp levels were not associated with gender, age, or the presence of schistosomiasis. However, lower N7-MedGp levels were found in normal DNA from individuals lacking the GSTM1 gene (P = 0.03) but not the GSTT1 gene or in subjects with the Ile105Val GSTP1 polymorphism. These results show that exposure to methylating agents is widespread and suggest that such exposure may play a role both in tumor initiation and progression. (Cancer Epidemiol Biomarkers Prev 2006;15(4):740–3)Keywords
This publication has 32 references indexed in Scilit:
- Levels of the DNA adduct, N7-methyldeoxyguanosine, are associated with increased risk of failure of treatment of cervical intraepithelial neoplasiaGynecologic Oncology, 2004
- Changes in the expression of cytochrome P450 2E1 and the activity of carcinogen-metabolizing enzymes in Schistosoma haematobium-infected human bladder tissuesToxicology, 2001
- Bladder cancer in Africa: UpdateSeminars in Oncology, 2001
- Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder CarcinomasThe American Journal of Pathology, 2000
- DNA adduct level in lung tissue may act as a risk biomarker of lung cancerEuropean Journal of Cancer, 2000
- Accurate and Sensitive Quantitation of N7-Methyldeoxyguanosine-3‘-monophosphate by 32P-Postlabeling and Storage-Phosphor ImagingChemical Research in Toxicology, 1997
- O6-Alkylguanine-DNA alkyltransferase activity in schistosomiasis-associated human bladder cancerEuropean Journal of Cancer, 1994
- Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patientsCarcinogenesis, 1994
- 32P-postlabelling analysis of DNA from human tissuesMutation Research Letters, 1992
- Association of bacteriuria and urinary nitrosamine formation with Schistosoma haematobium infection in the Qalyub area of EgyptTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982